Binu Malhotra

755 total citations
9 papers, 574 citations indexed

About

Binu Malhotra is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Binu Malhotra has authored 9 papers receiving a total of 574 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 2 papers in Surgery. Recurrent topics in Binu Malhotra's work include Lung Cancer Treatments and Mutations (4 papers), Head and Neck Cancer Studies (2 papers) and Lung Cancer Research Studies (2 papers). Binu Malhotra is often cited by papers focused on Lung Cancer Treatments and Mutations (4 papers), Head and Neck Cancer Studies (2 papers) and Lung Cancer Research Studies (2 papers). Binu Malhotra collaborates with scholars based in United States. Binu Malhotra's co-authors include Chinmay Patel, Gan‐Xin Yan, Harsh Patel, Prasad Gupta, Scott M. Schuetze, Corey J. Langer, Tracey L. Evans, Leslie A. Litzky, Christopher D. Watt and V.M. Van Deerlin and has published in prestigious journals such as Blood, Frontiers in Oncology and JAMA Network Open.

In The Last Decade

Binu Malhotra

8 papers receiving 554 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Binu Malhotra United States 6 408 124 109 69 56 9 574
Shmuel Schwartzenberg Israel 13 423 1.0× 117 0.9× 117 1.1× 47 0.7× 103 1.8× 34 612
Marie‐Laure Ozoux France 10 333 0.8× 63 0.5× 82 0.8× 43 0.6× 151 2.7× 18 581
Carmen Cristóbal Spain 12 214 0.5× 47 0.4× 83 0.8× 62 0.9× 114 2.0× 44 438
Manabu Uematsu Japan 14 163 0.4× 110 0.9× 68 0.6× 27 0.4× 106 1.9× 52 396
Ben Corden United Kingdom 9 303 0.7× 40 0.3× 73 0.7× 43 0.6× 36 0.6× 11 407
Hiroki Usuku Japan 13 228 0.6× 77 0.6× 200 1.8× 55 0.8× 45 0.8× 68 478
R. Stephen Krombach United States 10 314 0.8× 44 0.4× 89 0.8× 46 0.7× 53 0.9× 17 466
Pei Zhu China 12 162 0.4× 51 0.4× 92 0.8× 34 0.5× 79 1.4× 46 396
Michele Mattia Viscusi Italy 11 385 0.9× 46 0.4× 132 1.2× 43 0.6× 156 2.8× 50 563
Hiroki Hayashi Japan 8 217 0.5× 91 0.7× 136 1.2× 46 0.7× 136 2.4× 27 455

Countries citing papers authored by Binu Malhotra

Since Specialization
Citations

This map shows the geographic impact of Binu Malhotra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Binu Malhotra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Binu Malhotra more than expected).

Fields of papers citing papers by Binu Malhotra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Binu Malhotra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Binu Malhotra. The network helps show where Binu Malhotra may publish in the future.

Co-authorship network of co-authors of Binu Malhotra

This figure shows the co-authorship network connecting the top 25 collaborators of Binu Malhotra. A scholar is included among the top collaborators of Binu Malhotra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Binu Malhotra. Binu Malhotra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Kuriakose, Philip, et al.. (2025). Increasing Olanzapine Prescribing for Patients Undergoing Highly Emetogenic Chemotherapy. JAMA Network Open. 8(5). e2510392–e2510392.
2.
Malhotra, Binu, Shirish M. Gadgeel, Bryan J. Schneider, et al.. (2023). A Phase II Trial of Pevonedistat and Docetaxel in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer. Clinical Lung Cancer. 25(2). 128–134. 7 indexed citations
4.
Malhotra, Binu, James Moon, Joseph I. Clark, et al.. (2013). Phase II trial of biweekly gemcitabine and paclitaxel with recurrent or metastatic squamous cell carcinoma of the head and neck: Southwest Oncology Group study S0329. Head & Neck. 36(12). 1712–1717. 9 indexed citations
5.
Malhotra, Binu & Scott M. Schuetze. (2012). Dermatofibrosarcoma protruberans treatment with platelet-derived growth factor receptor inhibitor. Current Opinion in Oncology. 24(4). 419–424. 35 indexed citations
6.
Aisner, Dara L., Charuhas Deshpande, Zubair Baloch, et al.. (2011). Evaluation of EGFR mutation status in cytology specimens: An institutional experience. Diagnostic Cytopathology. 41(4). 316–323. 53 indexed citations
7.
Malhotra, Binu, Tracey L. Evans, Jared Weiss, et al.. (2010). Carboplatin/Pemetrexed/Bevacizumab in the Treatment of Patients With Advanced Non–Small-Cell Lung Cancer: A Single-Institution Experience. Clinical Lung Cancer. 11(3). 192–197. 10 indexed citations
8.
Malhotra, Binu, David Porter, Edward A. Stadtmauer, Stephen J. Schuster, & Dan T. Vogl. (2009). Continuous Infusion Cyclophosphamide as Salvage Therapy for Relapsed or Refractory Multiple Myeloma.. Blood. 114(22). 4942–4942. 1 indexed citations
9.
Gupta, Prasad, et al.. (2008). Tp-e/QT ratio as an index of arrhythmogenesis. Journal of Electrocardiology. 41(6). 567–574. 457 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026